Levomedetomidine is an alpha-2 adrenergic agonist and the (R)-enantiomer of medetomidine, acting as a potent sedative-hypnotic agent widely utilized in veterinary medicine for procedural sedation, analgesia,… Read more
Levomedetomidine is an alpha-2 adrenergic agonist and the (R)-enantiomer of medetomidine, acting as a potent sedative-hypnotic agent widely utilized in veterinary medicine for procedural sedation, analgesia, and muscle relaxation. This category provides essential chemical tools for research, including the parent drug, its hydrochloride salt form, and key metabolites like Levomedetomidine N1-Glucuronide. Laboratories rely on these high-quality reference standards for impurity profiling and method validation during pharmaceutical development. The inclusion of stable isotope-labelled compounds, such as Levomedetomidine-13C-d3 HCl, enables precise quantitative analysis and serves as an internal standard in mass spectrometry-based studies. These materials are critical for ensuring compliance with regulatory monographs, supporting accurate quality control, and investigating the pharmacokinetic profile of this specific isomer in biological matrices.